Renal hemodynamics in overweight and obesity: pathogenetic factors and targets for intervention

References

• Roudebush B, Ashley T, Titcomb CP Jr. Mortality and Morbidity Liaison Committee – ISCS body mass index study. J. Insur. Med.38(3), 167–180 (2006).
   PubMedGoogle Scholar
• Manson JE, Willett WC, Stampfer MJ et al. Body weight and mortality among women. N. Engl. J. Med.333(11), 677–685 (1995).
   PubMed Web of Science ®Google Scholar
• Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int. J. Obes. Relat. Metab. Disord.22(1), 39–47 (1998).
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States, 1991–1998. JAMA282(16), 1519–1522 (1999).
   PubMed Web of Science ®Google Scholar
• Stamler J. Epidemic obesity in the United States. Arch. Intern. Med.153(9), 1040–1044 (1993).
   PubMedGoogle Scholar
• Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA295(13), 1549–1555 (2006).
   PubMed Web of Science ®Google Scholar
• Centers for disease control and prevention. State-specific prevalence of obesity among adults- United States, 2005. Morb. Mortal. Wkly Rep. 15, 55(36), 985–988 (2006).
   PubMedGoogle Scholar
• Lobstein T, Rigby N, Leach R. International Obesity Task Force EU Platform Briefing Paper. Prepared in collaboration with the European Association for the Study of Obesity, March 15, 2005 Brussels, Belgium (2007).
   Google Scholar
• Meguid El NA, Bello AK. Chronic kidney disease: the global challenge. Lancet365(9456), 331–340 (2005).
   PubMed Web of Science ®Google Scholar
• Weisinger JR, Kempson RL, Eldridge FL, Swenson RS. The nephrotic syndrome: a complication of massive obesity. Ann. Intern. Med.81(4), 440–447 (1974).
   PubMed Web of Science ®Google Scholar
• Gonzalex A, Soderblom R, Teichman S. Nephrotic proteinuria in obesity. Ann. Intern. Med.82(1), 122 (1975).
   Google Scholar
• Warnke RA, Kempson RL. The nephrotic syndrome in massive obesity: a study by light, immunofluorescence, and electron microscopy. Arch. Pathol. Lab. Med.102(8), 431–438 (1978).
   PubMed Web of Science ®Google Scholar
• Bonnet F, Deprele C, Sassolas A et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am. J. Kidney Dis.37(4), 720–727 (2001).
   PubMed Web of Science ®Google Scholar
• Verani RR. Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am. J. Kidney Dis.20(6), 629–634 (1992).
   PubMedGoogle Scholar
• Jennette JC, Charles L, Grubb W. Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome. Am. J. Kidney Dis.10(6), 470–472 (1987).
   PubMed Web of Science ®Google Scholar
• Halme L, Eklund B, Kyllonen L, Salmela K. Is obesity still a risk factor in renal transplantation? Transpl. Int.10(4), 284–288 (1997).
   Google Scholar
• Meier-Kriesche HU, Vaghela M, Thambuganipalle R, Friedman G, Jacobs M, Kaplan B. The effect of body mass index on long-term renal allograft survival. Transplantation68(9), 1294–1297 (1999).
   Web of Science ®Google Scholar
• el-Agroudy AE, Wafa EW, Gheith OE, Shehab el-Dein AB, Ghoneim MA. Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation77(9), 1381–1385 (2004).
   PubMed Web of Science ®Google Scholar
• Bosma RJ, Kwakernaak AJ, Homan van der Heide JJ, de Jong PE, Navis GJ. Body mass index and glomerular hyperfiltration in renal transplant recipients: cross-sectional analysis and long-term impact. Am. J. Transplant.7(3), 645–652 (2007).
   PubMed Web of Science ®Google Scholar
• Praga M, Hernandez E, Herrero JC et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int.58(5), 2111–2118 (2000).
   Web of Science ®Google Scholar
• Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA291(7), 844–850 (2004).
   PubMed Web of Science ®Google Scholar
• Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int.65(5), 1870–1876 (2004).
   PubMed Web of Science ®Google Scholar
• Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann. Intern. Med.144(1), 21–28 (2006).
   PubMed Web of Science ®Google Scholar
• Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O. Obesity and risk for chronic renal failure. J. Am. Soc. Nephrol.17(6), 1695–1702 (2006).
   PubMed Web of Science ®Google Scholar
• Gelber RP, Kurth T, Kausz AT et al. Association between body mass index and CKD in apparently healthy men. Am. J. Kidney Dis.46(5), 871–880 (2005).
   PubMed Web of Science ®Google Scholar
• Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am. J. Kidney Dis.46(4), 587–594 (2005).
   PubMed Web of Science ®Google Scholar
• Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE. A central body fat distribution is related to renal function impairment, even in lean subjects. Am. J. Kidney Dis.41(4), 733–741 (2003).
   PubMed Web of Science ®Google Scholar
• Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann. Intern. Med.140(3), 167–174 (2004).
   PubMed Web of Science ®Google Scholar
• Fehrman-Ekholm I, Elinder CG, Stenbeck M, Tyden G, Groth CG. Kidney donors live longer. Transplantation64(7), 976–978 (1997).
   PubMed Web of Science ®Google Scholar
• Davis CL, Delmonico FL. Living-donor kidney transplantation: a review of the current practices for the live donor. J. Am. Soc. Nephrol.16(7), 2098–2110 (2005).
   PubMed Web of Science ®Google Scholar
• Rook M, Hofker HS, van Son WJ, Homan van der Heide JJ, Ploeg RJ, Navis GJ. Predictive capacity of pre-donation GFR and renal reserve capacity for donor renal function after living kidney donation. Am. J. Transplant.6(7), 1653–1659 (2006).
   Google Scholar
• Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int.23(4), 647–655 (1983).
   PubMed Web of Science ®Google Scholar
• Mogensen CE. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria? Diabetes39(7), 761–767 (1990).
   PubMed Web of Science ®Google Scholar
• Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. Functional and structural changes in the kidney in the early stages of obesity. J. Am. Soc. Nephrol.12(6), 1211–1217 (2001).
   PubMed Web of Science ®Google Scholar
• O’Donnell MP, Kasiske BL, Cleary MP, Keane WF. Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies. J. Lab. Clin. Med.106(5), 605–610 (1985).
   PubMedGoogle Scholar
• Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension28(6), 1047–1054 (1996).
   PubMed Web of Science ®Google Scholar
• Praga M, Ruilope LM, Alcazar JM, Martinez JM, Alonso P, Rodicio JL. Renin-mediated arterial hypertension in a case of congenital renal arteriovenous fistula. J. Urol.131(5), 937–938 (1984).
   Google Scholar
• Apperloo AJ, de ZD, Donker AJ, de Jong PE. Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. J. Am. Soc. Nephrol.7(4), 567–572 (1996).
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Beil AH, Weihprecht H, Messerli FH. How should renal hemodynamic data be indexed in obesity? J. Am. Soc. Nephrol.5(9), 1709–1713 (1995).
   Google Scholar
• Anastasio P, Spitali L, Frangiosa A et al. Glomerular filtration rate in severely overweight normotensive humans. Am. J. Kidney Dis.35(6), 1144–1148 (2000).
   PubMed Web of Science ®Google Scholar
• Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension26(4), 610–615 (1995).
   PubMed Web of Science ®Google Scholar
• Bosma RJ, Doorenbos CR, Stegeman CA, van der Heide JJ, Navis G. Predictive performance of renal function equations in renal transplant recipients: an analysis of patient factors in bias. Am. J. Transplant.5(9), 2193–2203 (2005).
   PubMedGoogle Scholar
• Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am. J. Physiol. Renal Physiol.278(5), F817–F822 (2000).
   PubMed Web of Science ®Google Scholar
• Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J. Am. Soc. Nephrol.14(6), 1480–1486 (2003).
   PubMed Web of Science ®Google Scholar
• Scaglione R, Ganguzza A, Corrao S et al. Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. Int. J. Obes. Relat. Metab. Disord.19(6), 403–409 (1995).
   PubMed Web of Science ®Google Scholar
• van Paassen P, de Zeeuw D, Navis G, de Jong PE. Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension? Hypertension27(2), 202–208 (1996).
   Google Scholar
• Porter LE, Hollenberg NK. Obesity, salt intake, and renal perfusion in healthy humans. Hypertension32(1), 144–148 (1998).
   PubMed Web of Science ®Google Scholar
• Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir MR. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension28(1), 127–132 (1996).
   PubMed Web of Science ®Google Scholar
• Krikken JA, Lely AT, Bakker SJ, Navis G. The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int.71(3), 260–265 (2007).
   Google Scholar
• Bosma RJ, van der Heide JJ, Oosterop EJ, de Jong PE, Navis G. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int.65(1), 259–265 (2004).
   Google Scholar
• Rea DJ, Heimbach JK, Grande JP et al. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int.70(9), 1636–1641 (2006).
   PubMed Web of Science ®Google Scholar
• Hirose K, Tsuchida H, Osterby R, Gundersen HJ. A strong correlation between glomerular filtration rate and filtration surface in diabetic kidney hyperfunction. Lab. Invest.43(5), 434–437 (1980).
   PubMed Web of Science ®Google Scholar
• Fogo A, Hawkins EP, Berry PL et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int.38(1), 115–123 (1990).
   PubMed Web of Science ®Google Scholar
• Apperloo AJ, de ZD, de Jong PE. A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney Int.51(3), 793–797 (1997).
   PubMed Web of Science ®Google Scholar
• Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving HH. Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int.47(6), 1726–1731 (1995).
   PubMed Web of Science ®Google Scholar
• Ahmed SB, Fisher ND, Stevanovic R, Hollenberg NK. Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension46(6), 1316–1320 (2005).
   PubMed Web of Science ®Google Scholar
• Price DA, Lansang MC, Osei SY, Fisher ND, Laffel LM, Hollenberg NK. Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan. Diabet. Med.19(10), 858–861 (2002).
   Google Scholar
• Chagnac A, Herman M, Singerman B et al. Effect of obesity-induced hyperfiltration on renal peritubular capillary oncotic pressure. J. Am. Soc. Nephrol.17, 686A (2006).
   Google Scholar
• Waki M, Kral JG, Mazariegos M, Wang J, Pierson RN Jr, Heymsfield SB. Relative expansion of extracellular fluid in obese vs. nonobese women. Am. J. Physiol.261(2 Pt 1), E199–E203 (1991).
   Google Scholar
• Rocchini AP, Key J, Bondie D et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N. Engl. J. Med.321(9), 580–585 (1989).
   PubMed Web of Science ®Google Scholar
• Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and the salt paradox in early [corrected] Type 1 diabetes mellitus: a tubulo-centric view. J. Am. Soc. Nephrol.14(2), 530–537 (2003).
   PubMed Web of Science ®Google Scholar
• Aviv A, Hollenberg NK, Weder AB. Sodium glomerulopathy: tubuloglomerular feedback and renal injury in African Americans. Kidney Int.65(2), 361–368 (2004).
   PubMed Web of Science ®Google Scholar
• Campese VM, Parise M, Karubian F, Bigazzi R. Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension18(6), 805–812 (1991).
   PubMed Web of Science ®Google Scholar
• Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M. Proximal sodium reabsorption: an independent determinant of blood pressure response to salt. Hypertension36(4), 631–637 (2000).
   PubMed Web of Science ®Google Scholar
• Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM. Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension23(2), 195–199 (1994).
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N. Engl. J. Med.346(12), 913–923 (2002).
   PubMed Web of Science ®Google Scholar
• Verhave JC, Hillege HL, Burgerhof JG et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J. Intern. Med.256(4), 324–330 (2004).
   PubMed Web of Science ®Google Scholar
• Luik PT, Hoogenberg K, Van Der Kleij FG et al. Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus. Diabetologia45(4), 535–541 (2002).
   Google Scholar
• He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA282(21), 2027–2034 (1999).
   PubMed Web of Science ®Google Scholar
• WHO. Obesity: preventing and managing the global epidemic. WHO Technical Report Series 894. WHO, Geneva, Switzerland (2000).
   Google Scholar
• Dutch Central Bureau for Statistics. Report No. PB06–034. Press release: 21 March 2006.
   Google Scholar
• Reisin E, Messerli FG, Ventura HO, Frohlich ED. Renal haemodynamic studies in obesity hypertension. J. Hypertens.5(4), 397–400 (1987).
   PubMed Web of Science ®Google Scholar
• Cook NR, Cutler JA, Obarzanek E et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the Trials of Hypertension Prevention (TOHP). Br. Med. J.28(334), 885–893 (2007).
   Google Scholar